Copper-Catalyzed Asymmetric Conjugate Addition: Building Chiral Quaternary Centers
Copper-catalyzed asymmetric conjugate addition (ACA) is the method of choice for constructing chiral β-substituted carbonyls and all-carbon quaternary stereocenters. Organozinc, Grignard, and organoaluminum reagents add to enones, enoates, and nitroalkenes in the β-position under control of a chiral Cu–ligand complex. The reaction is central to the synthesis of terpenes, prostaglandins, and APIs bearing quaternary centers.
Mechanism and Ligand Classes
The active Cu(I)–ligand complex undergoes transmetalation with the organometallic reagent, then inserts the enone in a 1,4-fashion. The chiral ligand controls facial selectivity during C–C bond formation. Two ligand classes dominate:
Phosphoramidite Ligands
Feringa’s BINOL-derived phosphoramidites (MonoPhos and analogs) are the most successful ligand class for Cu-catalyzed ACA. Their monodentate, modular nature allows rapid optimization. Mixed-ligand Cu complexes (two different phosphoramidites) often outperform homochiral combinations.
Bisoxazoline (BOX) Ligands
t-Bu-BOX-Cu complexes excel in Grignard additions to cyclic enones, delivering high ee for β-substituted cyclohexenones and cyclopentenones. The C₂-symmetric BOX creates a defined pocket that distinguishes enantiotopic faces.
Substrate and Reagent Scope
- Cyclic enones — cyclohexenone, cyclopentenone; quaternary centers accessible.
- Acyclic enones — more challenging; phosphoramidites typically required.
- Enoates and nitroalkenes — organozinc and Grignard reagents.
- Trisubstituted enones — generate all-carbon quaternary stereocenters.
Recommended Products
- (S)-MonoPhos — phosphoramidite for Cu-catalyzed ACA
- (R)-BINOL / (S)-BINOL — backbone for phosphoramidite library synthesis
- (S)-t-Bu-BOX / (R)-t-Bu-BOX — BOX ligand for cyclic enones
Industrial and Synthetic Impact
ACA is deployed in the synthesis of (R)-muscone, several prostaglandin analogs, and terpene natural products. The ability to construct quaternary stereocenters — a common feature of modern drug candidates — from simple enone and organometallic building blocks makes Cu-ACA indispensable in route scouting.
Recent Developments
Extensions include: (1) asymmetric 1,6-addition to dienones, (2) enantioselective borylative cyclization, (3) cooperative Cu/photoredox catalysis for radical ACA, and (4) continuous-flow ACA with immobilized Cu-phosphoramidite catalysts. The mild conditions and earth-abundant copper make ACA a green chemistry success story within asymmetric catalysis.